{"gene":"MTA3","run_date":"2026-06-10T02:59:51","timeline":{"discoveries":[{"year":2003,"finding":"MTA3 is an estrogen-dependent component of the Mi-2/NuRD transcriptional corepressor complex in breast epithelial cells; its absence leads to aberrant expression of the transcriptional repressor Snail, resulting in loss of E-cadherin expression and invasive growth.","method":"Co-immunoprecipitation, RNAi knockdown, reporter assays, Western blot; genetic epistasis placing MTA3 downstream of estrogen receptor and upstream of Snail/E-cadherin","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, RNAi rescue, epistasis across multiple orthogonal methods; foundational paper replicated by subsequent studies","pmids":["12705869"],"is_preprint":false},{"year":2004,"finding":"MTA3 is a cell-type-specific subunit of the Mi-2/NuRD corepressor complex that physically interacts with the transcription factor BCL-6 to mediate BCL-6-dependent repression of plasma cell differentiation genes in germinal center B cells; this interaction is sensitive to BCL-6 acetylation status, and MTA3 depletion by RNAi impairs BCL-6-dependent repression.","method":"Co-immunoprecipitation, RNAi knockdown, gene expression profiling, ectopic BCL-6 expression in plasma cell lines","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP demonstrating physical interaction, RNAi phenotype with rescue, multiple orthogonal methods, replicated in subsequent studies","pmids":["15454082"],"is_preprint":false},{"year":2001,"finding":"Mouse Mta3 (60 kDa) localizes to both nucleus and cytoplasm when GFP-tagged and expressed in keratinocytes, in contrast to Mta1 which is exclusively nuclear; Mta1 nuclear localization requires at least one NLS and one SH3 binding site, and Mta1 SH3 ligands interact with Grb2 and Fyn.","method":"GFP-fusion protein transfection and fluorescence microscopy, deletion constructs, co-immunoprecipitation with Grb2 and Fyn","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct live-cell localization with deletion constructs; single lab, two orthogonal methods","pmids":["11483358"],"is_preprint":false},{"year":2009,"finding":"Knockdown of mta3 by antisense morpholinos in zebrafish abolishes primitive hematopoietic lineages; overexpression of scl or scl/lmo2 rescues mta3 knockdown hematopoietic defects, placing Mta3-NuRD upstream of scl and lmo2 in the primitive hematopoiesis hierarchy; overexpression of mta3, MBD3, or HDAC1 enhances scl and lmo2 expression.","method":"Antisense morpholino knockdown in zebrafish, genetic epistasis by rescue with scl/lmo2 overexpression, HDAC inhibitor phenocopy experiments","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — morpholino KD + genetic epistasis + rescue in zebrafish with multiple orthogonal validations","pmids":["19864643"],"is_preprint":false},{"year":2012,"finding":"MTA3 interacts with NuRD proteins CHD4 and HDAC1 and the cohesin subunit RAD21 in mouse ovarian granulosa cells; MTA3 depletion slows granulosa cell proliferation (rescued by re-expression of exogenous MTA3), reduces cyclin B1 and B2 expression, and causes accumulation of cells in G2/M phase with reduced histone H3-Ser10 phosphorylation, indicating a role in G2/M progression.","method":"Co-immunoprecipitation in vivo, RNAi knockdown with rescue, cell cycle analysis, Western blot for cyclins and phospho-histone H3","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus RNAi with exogenous rescue, multiple functional readouts in one rigorous study","pmids":["22075476"],"is_preprint":false},{"year":2013,"finding":"In trophoblast cells, MTA3 directly occupies the proximal promoter regions of CGB5 (hCG β-subunit) and Snail as shown by ChIP; siRNA-mediated knockdown of MTA3 increases CGB5 and Snail promoter activity and their mRNA levels, establishing MTA3 as a direct transcriptional repressor of both genes.","method":"Chromatin immunoprecipitation (ChIP), siRNA knockdown, promoter-luciferase reporter assays, qRT-PCR","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — ChIP demonstrating direct promoter occupancy combined with promoter-reporter and KD, single lab, multiple orthogonal methods","pmids":["23510993"],"is_preprint":false},{"year":2015,"finding":"BCL-6 middle domain (RDII) recruits MTA3 to repress Prdm1 (Blimp1) and other target genes in T follicular helper (Tfh) cells; mimicked acetylation of BCL-6 K379Q prevents MTA3 recruitment and derepresses Prdm1, reducing Tfh differentiation in vivo; loss of BCL-6/MTA3 function could be partially rescued by abrogating Prdm1 expression.","method":"In vivo T cell differentiation with BCL-6 K379Q knock-in, ChIP, genetic rescue by Prdm1 ablation, flow cytometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo epistasis, ChIP, acetylation-mimetic mutation, genetic rescue; multiple orthogonal methods","pmids":["26460037"],"is_preprint":false},{"year":2016,"finding":"MTA3 is expressed predominantly in interstitial Leydig cells of rodent testis; shRNA-mediated ablation of Mta3 inhibits HCG/db-cAMP-stimulated progesterone secretion in MA-10 Leydig cells, while overexpression of MTA3 rescues Mta3-deficiency-impaired progesterone production, establishing a functional role for MTA3 in testicular steroidogenesis.","method":"shRNA knockdown, MTA3 overexpression, hormone stimulation assays, Western blot, qRT-PCR","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD and OE with functional steroidogenesis readout and rescue, single lab","pmids":["27673553"],"is_preprint":false},{"year":2017,"finding":"MTA3 knockdown in HTR8/SVneo extravillous trophoblast cells increases invasive capacity and upregulates MMP2, MMP9, and Snail; Co-IP/Western blot confirmed MTA3 interaction with HDAC1 (NuRD subunit); Co-IP/mass spectrometry identified 71 MTA3-interacting proteins including NuRD subunits, heterochromatin proteins, epigenetic modifiers, and transcription factors.","method":"shRNA lentiviral knockdown, transwell invasion assay, Co-immunoprecipitation-Western blot, Co-IP-mass spectrometry","journal":"AIMS medical science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with MS identification of interaction partners plus functional KD; single lab","pmids":["28959722"],"is_preprint":false},{"year":2018,"finding":"SIX3 physically associates with LSD1 and the NuRD(MTA3) complex; affinity purification-mass spectrometry identified this complex, which binds chromatin at WNT1 and FOXC2 target genes to suppress carcinogenesis and EMT in breast cancer cells.","method":"Affinity purification-mass spectrometry, ChIP-on-chip genome-wide analysis, functional invasion and proliferation assays","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — AP-MS identification of complex plus ChIP genome-wide; single lab, two orthogonal methods","pmids":["29463994"],"is_preprint":false},{"year":2018,"finding":"BPA-induced miR-146a-5p represses Mta3 expression by directly targeting its 3′UTR in murine Leydig cells, exacerbating BPA's inhibitory effects on testicular steroidogenesis; ectopic expression of hMTA3 rescues miR-146a-5p-elicited steroidogenic inhibition.","method":"3′UTR luciferase reporter assay, miR-146a-5p overexpression, hMTA3 rescue overexpression, Western blot, hormone assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3′UTR reporter validation, functional rescue, single lab","pmids":["29746863"],"is_preprint":false},{"year":2019,"finding":"MTA3 forms a repressive complex with GATA3, which directly downregulates the lncRNA SOX2OT, subsequently suppressing the SOX2OT/SOX2 axis to repress cancer cell stemness and metastasis in esophageal squamous cell carcinoma in vitro and in vivo.","method":"Co-immunoprecipitation (MTA3-GATA3 complex), ChIP, gene overexpression and knockdown, in vivo tumor models","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP demonstrating complex, ChIP at SOX2OT locus, in vivo validation; single lab","pmids":["31810000"],"is_preprint":false},{"year":2022,"finding":"MTA3, as a component of the Mi-2/NuRD complex, transcriptionally represses CRIP2 (a repressor of NF-κB/p65), thereby activating NF-κB signaling and inducing gemcitabine resistance in pancreatic ductal adenocarcinoma; GEM treatment increases MTA3 expression via STAT3 signaling.","method":"CRISPR/Cas9 activation library screen, ChIP, in vitro and in vivo functional assays, Western blot, patient-derived xenograft model","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide CRISPR screen identifying MTA3, ChIP demonstrating CRIP2 repression, in vivo PDX validation; single lab","pmids":["35981571"],"is_preprint":false},{"year":2022,"finding":"MTA3 functions downstream of SPHK1 to transcriptionally regulate PD-L1 expression in tumor cells, mediating immune evasion; MTA3 overexpression promotes PD-L1 upregulation and immune evasion, which is rescued by anti-PD-1 treatment.","method":"Functional knockdown/overexpression studies, immunocompetent mouse tumor models, T-cell co-culture assays, mechanistic analysis of SPHK1→MTA3→PD-L1 pathway","journal":"Cellular & molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo immunocompetent models with pathway epistasis, multiple functional readouts; single lab","pmids":["36050478"],"is_preprint":false},{"year":2023,"finding":"MTA3 physically interacts with HDAC2 (Co-IP validated); MTA3 overexpression decreases HDAC2 expression levels and rescues HDAC2-induced migration and invasion of NSCLC cells by reducing c-Myc and cyclin D1 expression.","method":"Co-immunoprecipitation, Western blot, CRISPR-edited cell lines (rs13213007 A/A genotype), wound-healing and Transwell assays, qRT-PCR","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP showing MTA3-HDAC2 interaction, functional rescue assays; single lab","pmids":["37401867"],"is_preprint":false},{"year":2022,"finding":"NR4A1 transcriptionally activates MTA3 in mouse Leydig cells; oxidative stress induced by T2DM suppresses NR4A1-mediated MTA3 transactivation, reducing MTA3 expression and impairing steroidogenesis; in vivo lentiviral MTA3 replenishment restores steroidogenesis and improves fertility in diabetic mice.","method":"NR4A1 transactivation assays, NR4A1 overexpression rescuing MTA3 expression, in vivo lentiviral gene transfer, testosterone/fertility measurements","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — NR4A1→MTA3 transcriptional axis demonstrated with overexpression rescue and in vivo gene transfer; single lab","pmids":["35239504"],"is_preprint":false},{"year":2024,"finding":"MTA3 represses MTA1 transcription (ChIP demonstrated MTA3 occupancy at MTA1 promoter), while MTA1 represses MTA3 transcription, forming a feedback loop; TRIM21 regulates MTA1 protein stability (ubiquitination assay); MTA3 inhibits MTA1-driven breast cancer stemness and EMT, and estrogen disrupts the MTA1/MTA3 balance.","method":"ChIP, luciferase reporter assay, immunoprecipitation, ubiquitination assay, in vitro and in vivo functional assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays demonstrating mutual transcriptional repression; multiple orthogonal methods; single lab","pmids":["39154024"],"is_preprint":false},{"year":2025,"finding":"MTA3 regulates fibroblast-to-myofibroblast transition via the p38 MAPK–E2F1 signaling pathway: MTA3 overexpression reduces α-SMA and Collagen I expression in cardiac fibroblasts, and E2F1 RNAi phenocopies this suppression; inhibition of p38 MAPK phosphorylation with SB203580 also reduces myofibroblast markers, indicating MTA3 operates through p-p38/E2F1.","method":"MTA3 overexpression plasmid transfection, RNAi of E2F1, SB203580 pharmacologic p38 inhibition, immunofluorescence, Western blot, qRT-PCR, myocardial infarction mouse model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic/pharmacologic perturbations delineating pathway; single lab, in vivo model","pmids":["40615041"],"is_preprint":false},{"year":2025,"finding":"Deletion of the BAH domain of Mta3 (Mta3ΔBAH allele) in mice yields viable, fertile animals with modest B lymphocyte activation defects; compound homozygosity for Mta3ΔBAH and Mta1 null alleles is synthetically lethal, revealing a genetic redundancy between Mta1 and Mta3; conditional deletion in B cells shows selection against loss in post-germinal center stages.","method":"CRISPR/Cas9 deletion of coding exons 1–2, genetic crosses for synthetic lethality, conditional B cell-specific deletion, B cell activation assays, antibody production assays, behavioral testing","journal":"G3 (Bethesda, Md.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic analysis with multiple mouse models; single study but rigorous genetic approach","pmids":["40758820"],"is_preprint":false},{"year":2026,"finding":"HDAC11 directly binds to MTA3 via its N-terminal region (demonstrated by GST pull-down and immunoprecipitation), forming a NuRD(MTA3) complex that transcriptionally represses TGFB1 to inhibit HCC metastasis.","method":"Mass spectrometry, immunoprecipitation, GST pull-down, transcriptomic analysis, siRNA knockdown, in vitro and in vivo assays","journal":"Clinical epigenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GST pull-down and Co-IP demonstrating direct N-terminal HDAC11–MTA3 interaction, transcriptomic validation; single lab","pmids":["41547814"],"is_preprint":false},{"year":2011,"finding":"Genistein inhibits JAR choriocarcinoma cell invasion through an ERβ-dependent mechanism involving MTA3: genistein decreases MTA3 mRNA, increases Snail mRNA, and upregulates E-cadherin protein; ERβ siRNA knockdown abolishes all these effects, placing ERβ upstream of MTA3/Snail/E-cadherin in this pathway.","method":"ERβ siRNA knockdown, Matrigel invasion assay, qRT-PCR, Western blot, epistasis by receptor KD","journal":"Oncology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis by ERβ KD with multiple molecular readouts; single lab","pmids":["22866146"],"is_preprint":false},{"year":2013,"finding":"MTA3 overexpression in HTR8/SVneo trophoblast cells upregulates HIF1α protein levels and increases HIF1α target gene expression (HRE-luciferase activity) under hypoxic conditions, indicating MTA3 positively regulates HIF1α activity in trophoblasts.","method":"MTA3 overexpression, HRE-luciferase reporter assay, Western blot for HIF1α, hypoxia treatment","journal":"Medical journal of obstetrics and gynecology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — overexpression with reporter assay, single lab, single method per readout, limited mechanistic depth","pmids":["25705708"],"is_preprint":false},{"year":2021,"finding":"Knockdown of MTA3 (but not MTA1) in human embryonic stem cells induces mesendoderm differentiation; DYRK inhibitor ID8 counteracts MTA3-knockdown-induced differentiation through DYRK4 activity, placing DYRK4 downstream of MTA3 in ESC pluripotency maintenance.","method":"siRNA knockdown, high-throughput transcriptomic sequencing, qRT-PCR, small molecule library screening with ID8, DYRK4 functional assay","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — KD with transcriptomic and pharmacologic follow-up; pathway placement is indirect; single lab","pmids":["33744762"],"is_preprint":false}],"current_model":"MTA3 is an integral, context-dependent subunit of the Mi-2/NuRD transcriptional corepressor complex that directly represses target gene promoters (including Snail, CGB5, CRIP2, TGFB1, and SOX2OT) and physically interacts with partners including BCL-6, GATA3, HDAC1, HDAC2, HDAC11, and SIX3/LSD1; in breast epithelial cells it is estrogen-dependent and suppresses EMT by repressing Snail/E-cadherin signaling, in germinal center B cells it mediates BCL-6-dependent repression of plasma cell fate in an acetylation-sensitive manner, in T follicular helper cells it is recruited by the BCL-6 middle domain to repress Blimp1, in granulosa cells it interacts with cohesin (RAD21) to regulate G2/M progression, and in Leydig cells its expression is driven by NR4A1 and supports steroidogenesis; genetic studies confirm synthetic lethality between Mta3 and Mta1 null alleles in mice, establishing partial functional redundancy within the NuRD complex."},"narrative":{"mechanistic_narrative":"MTA3 is a context-dependent subunit of the Mi-2/NuRD transcriptional corepressor complex that confers cell-type-specific gene repression across epithelial, immune, germ, and developmental programs [PMID:12705869, PMID:15454082]. In breast epithelial cells MTA3 acts downstream of estrogen receptor to repress the transcriptional repressor Snail, sustaining E-cadherin expression and restraining invasive growth [PMID:12705869]; this same MTA3–Snail axis is recapitulated in trophoblast cells, where MTA3 directly occupies and represses the Snail and CGB5 promoters [PMID:23510993]. In germinal center B cells MTA3 is recruited by the transcription factor BCL-6 to repress plasma cell differentiation genes, an interaction sensitive to BCL-6 acetylation [PMID:15454082], and in T follicular helper cells the BCL-6 middle domain recruits MTA3 to silence Prdm1/Blimp1, with acetylation-mimetic BCL-6 blocking recruitment and derepressing the target [PMID:26460037]. MTA3 partners with NuRD subunits and chromatin regulators including CHD4, HDAC1, HDAC2, and HDAC11, the last binding MTA3 through its N-terminal region to form a NuRD(MTA3) complex that represses TGFB1 [PMID:22075476, PMID:28959722, PMID:37401867, PMID:41547814], and it assembles with sequence-specific factors such as GATA3 and a SIX3/LSD1 module to repress targets including SOX2OT and EMT-associated genes [PMID:29463994, PMID:31810000]. Beyond transcriptional repression, MTA3 interacts with the cohesin subunit RAD21 and supports G2/M progression in granulosa cells [PMID:22075476], drives steroidogenesis in Leydig cells under transcriptional control by NR4A1 [PMID:27673553, PMID:35239504], and is required for primitive hematopoiesis upstream of scl/lmo2 in zebrafish [PMID:19864643]. MTA3 and its paralog MTA1 mutually repress one another's transcription and are genetically redundant, as compound Mta3-BAH-deletion/Mta1-null mice are synthetically lethal [PMID:39154024, PMID:40758820].","teleology":[{"year":2003,"claim":"Established MTA3 as a functional NuRD subunit linking estrogen signaling to epithelial integrity, answering whether MTA-family proteins have distinct, regulated roles in gene repression.","evidence":"Co-IP, RNAi, reporter assays and epistasis in breast epithelial cells","pmids":["12705869"],"confidence":"High","gaps":["Direct biochemical mechanism of Snail promoter recruitment not resolved","Did not address non-epithelial contexts"]},{"year":2004,"claim":"Showed MTA3 is a cell-type-specific NuRD subunit recruited by a sequence-specific transcription factor (BCL-6), explaining how NuRD achieves lineage-restricted repression.","evidence":"Reciprocal Co-IP, RNAi, expression profiling in germinal center B cells","pmids":["15454082"],"confidence":"High","gaps":["Structural basis of acetylation-sensitive BCL-6/MTA3 interaction not defined","In vivo requirement not tested at this stage"]},{"year":2009,"claim":"Placed Mta3-NuRD in a developmental hierarchy, demonstrating it is required upstream of scl/lmo2 for primitive hematopoiesis.","evidence":"Morpholino knockdown with scl/lmo2 rescue and HDAC inhibitor phenocopy in zebrafish","pmids":["19864643"],"confidence":"High","gaps":["Direct target genes of Mta3 in hematopoietic precursors not identified","Mammalian conservation of this hierarchy untested"]},{"year":2011,"claim":"Connected MTA3 regulation to ERβ signaling and dietary phytoestrogens, extending estrogen control of the MTA3/Snail/E-cadherin axis to choriocarcinoma invasion.","evidence":"ERβ siRNA epistasis with invasion assays and molecular readouts in JAR cells","pmids":["22866146"],"confidence":"Medium","gaps":["Whether ERβ regulates MTA3 directly or indirectly unresolved","Single cell-line context"]},{"year":2012,"claim":"Defined the in vivo recruitment determinant, showing the BCL-6 middle domain recruits MTA3 to repress Blimp1 and that BCL-6 acetylation gates this in T follicular helper differentiation.","evidence":"BCL-6 K379Q knock-in, ChIP, Prdm1-ablation rescue in vivo","pmids":["26460037"],"confidence":"High","gaps":["Full target repertoire beyond Prdm1 not mapped","Does not address other NuRD subunit contributions"]},{"year":2012,"claim":"Revealed a non-canonical role beyond transcriptional repression, linking MTA3 to cohesin and cell-cycle control.","evidence":"In vivo Co-IP with CHD4/HDAC1/RAD21 plus RNAi with rescue and cell-cycle analysis in granulosa cells","pmids":["22075476"],"confidence":"High","gaps":["Mechanism by which MTA3 promotes G2/M progression unresolved","Whether the RAD21 interaction is transcriptional or structural unclear"]},{"year":2013,"claim":"Provided direct evidence of promoter occupancy, demonstrating MTA3 binds and represses Snail and CGB5 promoters in trophoblasts.","evidence":"ChIP, siRNA, promoter-luciferase, qRT-PCR","pmids":["23510993"],"confidence":"High","gaps":["Recruiting transcription factor at these promoters not identified","NuRD subunit composition at these loci not defined"]},{"year":2016,"claim":"Established a tissue-specific role for MTA3 in testicular steroidogenesis distinct from its repressive functions.","evidence":"shRNA knockdown and overexpression rescue with hormone-stimulated progesterone assays in MA-10 Leydig cells","pmids":["27673553"],"confidence":"Medium","gaps":["Transcriptional targets driving steroidogenesis unknown","Whether NuRD complex is involved here untested"]},{"year":2018,"claim":"Expanded the MTA3 interactome and reinforced its EMT-suppressive role in trophoblast invasion, and identified a SIX3/LSD1 NuRD(MTA3) module suppressing breast cancer EMT.","evidence":"Co-IP/mass spectrometry (71 partners), invasion assays, and AP-MS with ChIP-on-chip","pmids":["28959722","29463994"],"confidence":"Medium","gaps":["Functional contribution of most identified partners untested","Direct vs indirect nature of many interactions unresolved"]},{"year":2018,"claim":"Identified an upstream regulatory axis, showing miR-146a-5p represses MTA3 via its 3'UTR to impair steroidogenesis under BPA exposure.","evidence":"3'UTR luciferase reporter, miR overexpression, hMTA3 rescue in Leydig cells","pmids":["29746863"],"confidence":"Medium","gaps":["Physiological relevance of miR-146a-5p targeting in vivo limited","Downstream steroidogenic targets not defined"]},{"year":2019,"claim":"Demonstrated MTA3 partners with GATA3 to repress an lncRNA (SOX2OT), linking MTA3 to control of cancer stemness via the SOX2OT/SOX2 axis.","evidence":"Co-IP, ChIP, overexpression/knockdown and in vivo tumor models in ESCC","pmids":["31810000"],"confidence":"Medium","gaps":["Whether GATA3 directly recruits MTA3 to the SOX2OT locus structurally unresolved","Single tumor type"]},{"year":2022,"claim":"Extended MTA3 function to therapy resistance and immune evasion, showing it represses CRIP2 to activate NF-κB and gemcitabine resistance, and acts downstream of SPHK1 to regulate PD-L1.","evidence":"CRISPR activation screen, ChIP, PDX models, and immunocompetent tumor models with T-cell co-culture","pmids":["35981571","36050478"],"confidence":"Medium","gaps":["Direct mechanism of PD-L1 transcriptional regulation by MTA3 not detailed","Context dependence of pro- vs anti-tumor MTA3 roles unresolved"]},{"year":2022,"claim":"Defined NR4A1 as a transcriptional activator of MTA3 in Leydig cells, integrating MTA3 into oxidative-stress-sensitive steroidogenic control.","evidence":"NR4A1 transactivation assays, overexpression rescue, in vivo lentiviral replenishment in diabetic mice","pmids":["35239504"],"confidence":"Medium","gaps":["Direct NR4A1 binding site on MTA3 promoter not mapped","Mechanistic link between MTA3 and steroidogenic enzymes unresolved"]},{"year":2023,"claim":"Showed MTA3 physically interacts with and downregulates HDAC2, suppressing NSCLC migration via reduced c-Myc and cyclin D1.","evidence":"Co-IP, CRISPR-edited cell lines, wound-healing/Transwell assays, qRT-PCR","pmids":["37401867"],"confidence":"Medium","gaps":["Mechanism by which MTA3 lowers HDAC2 levels unclear","Reconciliation of HDAC2 partnership vs repression untested"]},{"year":2024,"claim":"Revealed a mutual transcriptional repression loop between MTA3 and MTA1 that estrogen disrupts, framing MTA3 as an antagonist of MTA1-driven breast cancer stemness/EMT.","evidence":"ChIP, luciferase reporter, ubiquitination assay, in vitro/in vivo functional assays","pmids":["39154024"],"confidence":"Medium","gaps":["Quantitative balance setpoint of the MTA1/MTA3 loop not defined","Role of TRIM21-mediated MTA1 stability in the loop incompletely resolved"]},{"year":2025,"claim":"Extended MTA3 to fibroblast biology, placing it upstream of p38 MAPK/E2F1 in suppressing fibroblast-to-myofibroblast transition, and defined an HDAC11-MTA3 complex repressing TGFB1.","evidence":"Overexpression, E2F1 RNAi, SB203580 inhibition and MI model; GST pull-down/Co-IP with transcriptomics in HCC","pmids":["40615041","41547814"],"confidence":"Medium","gaps":["Direct transcriptional targets bridging MTA3 to p38/E2F1 not identified","Whether HDAC11-MTA3 acts at the TGFB1 promoter directly via ChIP not shown in narrative"]},{"year":2025,"claim":"Provided in vivo genetic proof of functional redundancy within NuRD, showing Mta3 BAH-domain loss is tolerated alone but synthetically lethal with Mta1 null.","evidence":"CRISPR deletion, synthetic lethality crosses, conditional B-cell deletion in mice","pmids":["40758820"],"confidence":"Medium","gaps":["Molecular function of the MTA3 BAH domain not defined","Shared vs distinct target genes underlying redundancy not mapped"]},{"year":null,"claim":"How MTA3 selects between repressive (Snail, Blimp1, CRIP2, TGFB1) and context-specific activating/structural roles (steroidogenesis, cohesin/cell cycle, PD-L1) within a single NuRD framework remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying biochemical model distinguishing MTA3 target selection across tissues","Structural determinants of partner-specific recruitment undefined","Genome-wide direct target maps across cell types incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,5,6,11,12,16,19]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,6,11,12,16]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,6,9,11]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,1,4,19]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,5,6,11,12,16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,6,7]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,6,13,18]}],"complexes":["Mi-2/NuRD complex"],"partners":["BCL6","GATA3","HDAC1","HDAC2","HDAC11","CHD4","RAD21","MTA1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9BTC8","full_name":"Metastasis-associated protein MTA3","aliases":[],"length_aa":594,"mass_kda":67.5,"function":"Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:12705869, PubMed:16428440, PubMed:28977666). Plays a role in maintenance of the normal epithelial architecture through the repression of SNAI1 transcription in a histone deacetylase-dependent manner, and thus the regulation of E-cadherin levels (PubMed:12705869). Contributes to transcriptional repression by BCL6 (PubMed:15454082)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9BTC8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MTA3","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HDAC1","stoichiometry":0.2},{"gene":"HDAC2","stoichiometry":0.2},{"gene":"MED31","stoichiometry":0.2},{"gene":"RBBP4","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MTA3","total_profiled":1310},"omim":[{"mim_id":"615786","title":"NACC FAMILY, MEMBER 2, BEN AND BTB/POZ DOMAINS-CONTAINING; NACC2","url":"https://www.omim.org/entry/615786"},{"mim_id":"609050","title":"METASTASIS-ASSOCIATED GENE 3; MTA3","url":"https://www.omim.org/entry/609050"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":65.6}],"url":"https://www.proteinatlas.org/search/MTA3"},"hgnc":{"alias_symbol":["KIAA1266"],"prev_symbol":[]},"alphafold":{"accession":"Q9BTC8","domains":[{"cath_id":"2.30.30.490","chopping":"1-144","consensus_level":"high","plddt":88.086,"start":1,"end":144},{"cath_id":"4.10.1240.50","chopping":"189-265","consensus_level":"high","plddt":91.1574,"start":189,"end":265},{"cath_id":"1.10.10.60","chopping":"276-331","consensus_level":"high","plddt":94.8804,"start":276,"end":331},{"cath_id":"3.30.50","chopping":"345-351_377-419","consensus_level":"medium","plddt":89.7796,"start":345,"end":419},{"cath_id":"-","chopping":"475-512","consensus_level":"high","plddt":87.6479,"start":475,"end":512}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BTC8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BTC8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BTC8-F1-predicted_aligned_error_v6.png","plddt_mean":78.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MTA3","jax_strain_url":"https://www.jax.org/strain/search?query=MTA3"},"sequence":{"accession":"Q9BTC8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BTC8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BTC8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BTC8"}},"corpus_meta":[{"pmid":"12705869","id":"PMC_12705869","title":"MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12705869","citation_count":425,"is_preprint":false},{"pmid":"15454082","id":"PMC_15454082","title":"MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.","date":"2004","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15454082","citation_count":279,"is_preprint":false},{"pmid":"24293376","id":"PMC_24293376","title":"MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24293376","citation_count":47,"is_preprint":false},{"pmid":"19864643","id":"PMC_19864643","title":"Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19864643","citation_count":43,"is_preprint":false},{"pmid":"19363681","id":"PMC_19363681","title":"The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells.","date":"2009","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19363681","citation_count":42,"is_preprint":false},{"pmid":"29746863","id":"PMC_29746863","title":"Bisphenol A-elicited miR-146a-5p impairs murine testicular steroidogenesis through negative regulation of Mta3 signaling.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29746863","citation_count":42,"is_preprint":false},{"pmid":"11483358","id":"PMC_11483358","title":"Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11483358","citation_count":39,"is_preprint":false},{"pmid":"29463994","id":"PMC_29463994","title":"The Homeotic Protein SIX3 Suppresses Carcinogenesis and Metastasis through Recruiting the LSD1/NuRD(MTA3) Complex.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/29463994","citation_count":34,"is_preprint":false},{"pmid":"26460037","id":"PMC_26460037","title":"Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26460037","citation_count":34,"is_preprint":false},{"pmid":"31145886","id":"PMC_31145886","title":"Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.","date":"2019","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31145886","citation_count":28,"is_preprint":false},{"pmid":"20865667","id":"PMC_20865667","title":"The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas.","date":"2010","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/20865667","citation_count":28,"is_preprint":false},{"pmid":"30706982","id":"PMC_30706982","title":"Long non-coding RNA HCG11 suppresses the growth of glioma by cooperating with the miR-4425/MTA3 axis.","date":"2019","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30706982","citation_count":26,"is_preprint":false},{"pmid":"17573669","id":"PMC_17573669","title":"The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.","date":"2007","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17573669","citation_count":25,"is_preprint":false},{"pmid":"23840517","id":"PMC_23840517","title":"Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23840517","citation_count":24,"is_preprint":false},{"pmid":"36050478","id":"PMC_36050478","title":"Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis.","date":"2022","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36050478","citation_count":23,"is_preprint":false},{"pmid":"28968973","id":"PMC_28968973","title":"MiR-367 regulates cell proliferation and metastasis by targeting metastasis-associated protein 3 (MTA3) in clear-cell renal cell carcinoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28968973","citation_count":23,"is_preprint":false},{"pmid":"31810000","id":"PMC_31810000","title":"MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/31810000","citation_count":22,"is_preprint":false},{"pmid":"27673553","id":"PMC_27673553","title":"Regulated and Functional Expression of the Corepressor MTA3 in Rodent Testis.","date":"2016","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27673553","citation_count":21,"is_preprint":false},{"pmid":"23510993","id":"PMC_23510993","title":"MTA3 regulates CGB5 and Snail genes in trophoblast.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23510993","citation_count":21,"is_preprint":false},{"pmid":"35981571","id":"PMC_35981571","title":"Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/35981571","citation_count":21,"is_preprint":false},{"pmid":"22075476","id":"PMC_22075476","title":"Metastasis-associated protein 3 (MTA3) regulates G2/M progression in proliferating mouse granulosa cells.","date":"2012","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/22075476","citation_count":19,"is_preprint":false},{"pmid":"30281099","id":"PMC_30281099","title":"Genome-wide meta-analysis identifies BARX1 and EML4-MTA3 as new loci associated with infantile hypertrophic pyloric stenosis.","date":"2019","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30281099","citation_count":18,"is_preprint":false},{"pmid":"27033852","id":"PMC_27033852","title":"The Many Faces of MTA3 Protein in Normal Development and Cancers.","date":"2016","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/27033852","citation_count":15,"is_preprint":false},{"pmid":"25319202","id":"PMC_25319202","title":"Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.","date":"2014","source":"Cancer metastasis reviews","url":"https://pubmed.ncbi.nlm.nih.gov/25319202","citation_count":15,"is_preprint":false},{"pmid":"31552166","id":"PMC_31552166","title":"MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma.","date":"2019","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31552166","citation_count":15,"is_preprint":false},{"pmid":"28351306","id":"PMC_28351306","title":"MTA3 regulates malignant progression of colorectal cancer through Wnt signaling pathway.","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28351306","citation_count":14,"is_preprint":false},{"pmid":"22866146","id":"PMC_22866146","title":"Genistein inhibits placental choriocarcinoma cell line JAR invasion through ERβ/MTA3/Snail/E-cadherin pathway.","date":"2011","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/22866146","citation_count":14,"is_preprint":false},{"pmid":"25705708","id":"PMC_25705708","title":"MTA1 and MTA3 Regulate HIF1a Expression in Hypoxia-Treated Human Trophoblast Cell Line HTR8/Svneo.","date":"2013","source":"Medical journal of obstetrics and gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/25705708","citation_count":13,"is_preprint":false},{"pmid":"30816482","id":"PMC_30816482","title":"High glucose promotes hepatic fibrosis via miR‑32/MTA3‑mediated epithelial‑to‑mesenchymal transition.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30816482","citation_count":13,"is_preprint":false},{"pmid":"35809308","id":"PMC_35809308","title":"lncRNA PCAT1 might coordinate ZNF217 to promote CRC adhesion and invasion through regulating MTA2/MTA3/Snai1/E-cadherin signaling.","date":"2022","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/35809308","citation_count":11,"is_preprint":false},{"pmid":"26198267","id":"PMC_26198267","title":"MTA3 regulates differentiation of human cytotrophoblast stem cells.","date":"2015","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/26198267","citation_count":10,"is_preprint":false},{"pmid":"33744762","id":"PMC_33744762","title":"Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33744762","citation_count":9,"is_preprint":false},{"pmid":"37401867","id":"PMC_37401867","title":"The HDAC2-MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c-Myc and cyclin D1.","date":"2023","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/37401867","citation_count":9,"is_preprint":false},{"pmid":"39154024","id":"PMC_39154024","title":"The feedback loop between MTA1 and MTA3/TRIM21 modulates stemness of breast cancer in response to estrogen.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39154024","citation_count":8,"is_preprint":false},{"pmid":"35037193","id":"PMC_35037193","title":"The effect of progesterone administration on the expression of metastasis tumor antigens (MTA1 and MTA3) in placentas of normal and dexamethasone-treated rats.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35037193","citation_count":6,"is_preprint":false},{"pmid":"35239504","id":"PMC_35239504","title":"T2DM-elicited oxidative stress represses MTA3 expression in mouse Leydig cells.","date":"2022","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35239504","citation_count":5,"is_preprint":false},{"pmid":"26483332","id":"PMC_26483332","title":"[Regulation Mechanism of MTA3 in the Apoptosis of NSCLC Cells].","date":"2015","source":"Zhongguo fei ai za zhi = Chinese journal of lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26483332","citation_count":4,"is_preprint":false},{"pmid":"40803231","id":"PMC_40803231","title":"MiR-138 reprograms dental pulp stem cells into GABAergic neurons via the GATAD2B/MTA3/WNTs axis for stroke treatment.","date":"2025","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/40803231","citation_count":3,"is_preprint":false},{"pmid":"40615041","id":"PMC_40615041","title":"The metastasis-associated protein MTA3 promotes cardiac repair by inhibiting the fibroblast to myofibroblast transition during fibrosis.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40615041","citation_count":2,"is_preprint":false},{"pmid":"28959722","id":"PMC_28959722","title":"MTA3 Regulates Extravillous Trophoblast Invasion Through NuRD Complex.","date":"2017","source":"AIMS medical science","url":"https://pubmed.ncbi.nlm.nih.gov/28959722","citation_count":2,"is_preprint":false},{"pmid":"39455636","id":"PMC_39455636","title":"Discovery of Jaspamycin from marine-derived natural product based on MTA3 to inhibit hepatocellular carcinoma progression.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39455636","citation_count":1,"is_preprint":false},{"pmid":"29949275","id":"PMC_29949275","title":"Immunohistochemical expression of MTA1 and MTA3 in placental tissue of normal and preeclamptic pregnancies.","date":"2017","source":"Clinical and experimental obstetrics & gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/29949275","citation_count":1,"is_preprint":false},{"pmid":"40758820","id":"PMC_40758820","title":"A novel mutant allele of Mta3 in the mouse: genetic analysis of roles in immunity and androgen biology.","date":"2025","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/40758820","citation_count":1,"is_preprint":false},{"pmid":"36004471","id":"PMC_36004471","title":"[Corrigendum] High glucose promotes hepatic fibrosis via miR‑32/MTA3‑mediated epithelial‑to‑mesenchymal transition.","date":"2022","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/36004471","citation_count":1,"is_preprint":false},{"pmid":"41584603","id":"PMC_41584603","title":"Mechanisms of MTA3 in cancer and related diseases and its clinical applications.","date":"2026","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41584603","citation_count":0,"is_preprint":false},{"pmid":"41547814","id":"PMC_41547814","title":"HDAC11 interacts with the NuRD (MTA3) complex to transcriptionally suppress TGFβ1 expression and inhibit hepatocellular carcinoma metastasis.","date":"2026","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/41547814","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24581,"output_tokens":5900,"usd":0.081121,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14507,"output_tokens":5213,"usd":0.10143,"stage2_stop_reason":"end_turn"},"total_usd":0.182551,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"MTA3 is an estrogen-dependent component of the Mi-2/NuRD transcriptional corepressor complex in breast epithelial cells; its absence leads to aberrant expression of the transcriptional repressor Snail, resulting in loss of E-cadherin expression and invasive growth.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, reporter assays, Western blot; genetic epistasis placing MTA3 downstream of estrogen receptor and upstream of Snail/E-cadherin\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, RNAi rescue, epistasis across multiple orthogonal methods; foundational paper replicated by subsequent studies\",\n      \"pmids\": [\"12705869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MTA3 is a cell-type-specific subunit of the Mi-2/NuRD corepressor complex that physically interacts with the transcription factor BCL-6 to mediate BCL-6-dependent repression of plasma cell differentiation genes in germinal center B cells; this interaction is sensitive to BCL-6 acetylation status, and MTA3 depletion by RNAi impairs BCL-6-dependent repression.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, gene expression profiling, ectopic BCL-6 expression in plasma cell lines\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP demonstrating physical interaction, RNAi phenotype with rescue, multiple orthogonal methods, replicated in subsequent studies\",\n      \"pmids\": [\"15454082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mouse Mta3 (60 kDa) localizes to both nucleus and cytoplasm when GFP-tagged and expressed in keratinocytes, in contrast to Mta1 which is exclusively nuclear; Mta1 nuclear localization requires at least one NLS and one SH3 binding site, and Mta1 SH3 ligands interact with Grb2 and Fyn.\",\n      \"method\": \"GFP-fusion protein transfection and fluorescence microscopy, deletion constructs, co-immunoprecipitation with Grb2 and Fyn\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct live-cell localization with deletion constructs; single lab, two orthogonal methods\",\n      \"pmids\": [\"11483358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Knockdown of mta3 by antisense morpholinos in zebrafish abolishes primitive hematopoietic lineages; overexpression of scl or scl/lmo2 rescues mta3 knockdown hematopoietic defects, placing Mta3-NuRD upstream of scl and lmo2 in the primitive hematopoiesis hierarchy; overexpression of mta3, MBD3, or HDAC1 enhances scl and lmo2 expression.\",\n      \"method\": \"Antisense morpholino knockdown in zebrafish, genetic epistasis by rescue with scl/lmo2 overexpression, HDAC inhibitor phenocopy experiments\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — morpholino KD + genetic epistasis + rescue in zebrafish with multiple orthogonal validations\",\n      \"pmids\": [\"19864643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MTA3 interacts with NuRD proteins CHD4 and HDAC1 and the cohesin subunit RAD21 in mouse ovarian granulosa cells; MTA3 depletion slows granulosa cell proliferation (rescued by re-expression of exogenous MTA3), reduces cyclin B1 and B2 expression, and causes accumulation of cells in G2/M phase with reduced histone H3-Ser10 phosphorylation, indicating a role in G2/M progression.\",\n      \"method\": \"Co-immunoprecipitation in vivo, RNAi knockdown with rescue, cell cycle analysis, Western blot for cyclins and phospho-histone H3\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus RNAi with exogenous rescue, multiple functional readouts in one rigorous study\",\n      \"pmids\": [\"22075476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In trophoblast cells, MTA3 directly occupies the proximal promoter regions of CGB5 (hCG β-subunit) and Snail as shown by ChIP; siRNA-mediated knockdown of MTA3 increases CGB5 and Snail promoter activity and their mRNA levels, establishing MTA3 as a direct transcriptional repressor of both genes.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), siRNA knockdown, promoter-luciferase reporter assays, qRT-PCR\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP demonstrating direct promoter occupancy combined with promoter-reporter and KD, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23510993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BCL-6 middle domain (RDII) recruits MTA3 to repress Prdm1 (Blimp1) and other target genes in T follicular helper (Tfh) cells; mimicked acetylation of BCL-6 K379Q prevents MTA3 recruitment and derepresses Prdm1, reducing Tfh differentiation in vivo; loss of BCL-6/MTA3 function could be partially rescued by abrogating Prdm1 expression.\",\n      \"method\": \"In vivo T cell differentiation with BCL-6 K379Q knock-in, ChIP, genetic rescue by Prdm1 ablation, flow cytometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo epistasis, ChIP, acetylation-mimetic mutation, genetic rescue; multiple orthogonal methods\",\n      \"pmids\": [\"26460037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MTA3 is expressed predominantly in interstitial Leydig cells of rodent testis; shRNA-mediated ablation of Mta3 inhibits HCG/db-cAMP-stimulated progesterone secretion in MA-10 Leydig cells, while overexpression of MTA3 rescues Mta3-deficiency-impaired progesterone production, establishing a functional role for MTA3 in testicular steroidogenesis.\",\n      \"method\": \"shRNA knockdown, MTA3 overexpression, hormone stimulation assays, Western blot, qRT-PCR\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD and OE with functional steroidogenesis readout and rescue, single lab\",\n      \"pmids\": [\"27673553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MTA3 knockdown in HTR8/SVneo extravillous trophoblast cells increases invasive capacity and upregulates MMP2, MMP9, and Snail; Co-IP/Western blot confirmed MTA3 interaction with HDAC1 (NuRD subunit); Co-IP/mass spectrometry identified 71 MTA3-interacting proteins including NuRD subunits, heterochromatin proteins, epigenetic modifiers, and transcription factors.\",\n      \"method\": \"shRNA lentiviral knockdown, transwell invasion assay, Co-immunoprecipitation-Western blot, Co-IP-mass spectrometry\",\n      \"journal\": \"AIMS medical science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with MS identification of interaction partners plus functional KD; single lab\",\n      \"pmids\": [\"28959722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SIX3 physically associates with LSD1 and the NuRD(MTA3) complex; affinity purification-mass spectrometry identified this complex, which binds chromatin at WNT1 and FOXC2 target genes to suppress carcinogenesis and EMT in breast cancer cells.\",\n      \"method\": \"Affinity purification-mass spectrometry, ChIP-on-chip genome-wide analysis, functional invasion and proliferation assays\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — AP-MS identification of complex plus ChIP genome-wide; single lab, two orthogonal methods\",\n      \"pmids\": [\"29463994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BPA-induced miR-146a-5p represses Mta3 expression by directly targeting its 3′UTR in murine Leydig cells, exacerbating BPA's inhibitory effects on testicular steroidogenesis; ectopic expression of hMTA3 rescues miR-146a-5p-elicited steroidogenic inhibition.\",\n      \"method\": \"3′UTR luciferase reporter assay, miR-146a-5p overexpression, hMTA3 rescue overexpression, Western blot, hormone assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3′UTR reporter validation, functional rescue, single lab\",\n      \"pmids\": [\"29746863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MTA3 forms a repressive complex with GATA3, which directly downregulates the lncRNA SOX2OT, subsequently suppressing the SOX2OT/SOX2 axis to repress cancer cell stemness and metastasis in esophageal squamous cell carcinoma in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation (MTA3-GATA3 complex), ChIP, gene overexpression and knockdown, in vivo tumor models\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP demonstrating complex, ChIP at SOX2OT locus, in vivo validation; single lab\",\n      \"pmids\": [\"31810000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MTA3, as a component of the Mi-2/NuRD complex, transcriptionally represses CRIP2 (a repressor of NF-κB/p65), thereby activating NF-κB signaling and inducing gemcitabine resistance in pancreatic ductal adenocarcinoma; GEM treatment increases MTA3 expression via STAT3 signaling.\",\n      \"method\": \"CRISPR/Cas9 activation library screen, ChIP, in vitro and in vivo functional assays, Western blot, patient-derived xenograft model\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide CRISPR screen identifying MTA3, ChIP demonstrating CRIP2 repression, in vivo PDX validation; single lab\",\n      \"pmids\": [\"35981571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MTA3 functions downstream of SPHK1 to transcriptionally regulate PD-L1 expression in tumor cells, mediating immune evasion; MTA3 overexpression promotes PD-L1 upregulation and immune evasion, which is rescued by anti-PD-1 treatment.\",\n      \"method\": \"Functional knockdown/overexpression studies, immunocompetent mouse tumor models, T-cell co-culture assays, mechanistic analysis of SPHK1→MTA3→PD-L1 pathway\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo immunocompetent models with pathway epistasis, multiple functional readouts; single lab\",\n      \"pmids\": [\"36050478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MTA3 physically interacts with HDAC2 (Co-IP validated); MTA3 overexpression decreases HDAC2 expression levels and rescues HDAC2-induced migration and invasion of NSCLC cells by reducing c-Myc and cyclin D1 expression.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, CRISPR-edited cell lines (rs13213007 A/A genotype), wound-healing and Transwell assays, qRT-PCR\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP showing MTA3-HDAC2 interaction, functional rescue assays; single lab\",\n      \"pmids\": [\"37401867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NR4A1 transcriptionally activates MTA3 in mouse Leydig cells; oxidative stress induced by T2DM suppresses NR4A1-mediated MTA3 transactivation, reducing MTA3 expression and impairing steroidogenesis; in vivo lentiviral MTA3 replenishment restores steroidogenesis and improves fertility in diabetic mice.\",\n      \"method\": \"NR4A1 transactivation assays, NR4A1 overexpression rescuing MTA3 expression, in vivo lentiviral gene transfer, testosterone/fertility measurements\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — NR4A1→MTA3 transcriptional axis demonstrated with overexpression rescue and in vivo gene transfer; single lab\",\n      \"pmids\": [\"35239504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MTA3 represses MTA1 transcription (ChIP demonstrated MTA3 occupancy at MTA1 promoter), while MTA1 represses MTA3 transcription, forming a feedback loop; TRIM21 regulates MTA1 protein stability (ubiquitination assay); MTA3 inhibits MTA1-driven breast cancer stemness and EMT, and estrogen disrupts the MTA1/MTA3 balance.\",\n      \"method\": \"ChIP, luciferase reporter assay, immunoprecipitation, ubiquitination assay, in vitro and in vivo functional assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays demonstrating mutual transcriptional repression; multiple orthogonal methods; single lab\",\n      \"pmids\": [\"39154024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MTA3 regulates fibroblast-to-myofibroblast transition via the p38 MAPK–E2F1 signaling pathway: MTA3 overexpression reduces α-SMA and Collagen I expression in cardiac fibroblasts, and E2F1 RNAi phenocopies this suppression; inhibition of p38 MAPK phosphorylation with SB203580 also reduces myofibroblast markers, indicating MTA3 operates through p-p38/E2F1.\",\n      \"method\": \"MTA3 overexpression plasmid transfection, RNAi of E2F1, SB203580 pharmacologic p38 inhibition, immunofluorescence, Western blot, qRT-PCR, myocardial infarction mouse model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic/pharmacologic perturbations delineating pathway; single lab, in vivo model\",\n      \"pmids\": [\"40615041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Deletion of the BAH domain of Mta3 (Mta3ΔBAH allele) in mice yields viable, fertile animals with modest B lymphocyte activation defects; compound homozygosity for Mta3ΔBAH and Mta1 null alleles is synthetically lethal, revealing a genetic redundancy between Mta1 and Mta3; conditional deletion in B cells shows selection against loss in post-germinal center stages.\",\n      \"method\": \"CRISPR/Cas9 deletion of coding exons 1–2, genetic crosses for synthetic lethality, conditional B cell-specific deletion, B cell activation assays, antibody production assays, behavioral testing\",\n      \"journal\": \"G3 (Bethesda, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic analysis with multiple mouse models; single study but rigorous genetic approach\",\n      \"pmids\": [\"40758820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"HDAC11 directly binds to MTA3 via its N-terminal region (demonstrated by GST pull-down and immunoprecipitation), forming a NuRD(MTA3) complex that transcriptionally represses TGFB1 to inhibit HCC metastasis.\",\n      \"method\": \"Mass spectrometry, immunoprecipitation, GST pull-down, transcriptomic analysis, siRNA knockdown, in vitro and in vivo assays\",\n      \"journal\": \"Clinical epigenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GST pull-down and Co-IP demonstrating direct N-terminal HDAC11–MTA3 interaction, transcriptomic validation; single lab\",\n      \"pmids\": [\"41547814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Genistein inhibits JAR choriocarcinoma cell invasion through an ERβ-dependent mechanism involving MTA3: genistein decreases MTA3 mRNA, increases Snail mRNA, and upregulates E-cadherin protein; ERβ siRNA knockdown abolishes all these effects, placing ERβ upstream of MTA3/Snail/E-cadherin in this pathway.\",\n      \"method\": \"ERβ siRNA knockdown, Matrigel invasion assay, qRT-PCR, Western blot, epistasis by receptor KD\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis by ERβ KD with multiple molecular readouts; single lab\",\n      \"pmids\": [\"22866146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MTA3 overexpression in HTR8/SVneo trophoblast cells upregulates HIF1α protein levels and increases HIF1α target gene expression (HRE-luciferase activity) under hypoxic conditions, indicating MTA3 positively regulates HIF1α activity in trophoblasts.\",\n      \"method\": \"MTA3 overexpression, HRE-luciferase reporter assay, Western blot for HIF1α, hypoxia treatment\",\n      \"journal\": \"Medical journal of obstetrics and gynecology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — overexpression with reporter assay, single lab, single method per readout, limited mechanistic depth\",\n      \"pmids\": [\"25705708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Knockdown of MTA3 (but not MTA1) in human embryonic stem cells induces mesendoderm differentiation; DYRK inhibitor ID8 counteracts MTA3-knockdown-induced differentiation through DYRK4 activity, placing DYRK4 downstream of MTA3 in ESC pluripotency maintenance.\",\n      \"method\": \"siRNA knockdown, high-throughput transcriptomic sequencing, qRT-PCR, small molecule library screening with ID8, DYRK4 functional assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — KD with transcriptomic and pharmacologic follow-up; pathway placement is indirect; single lab\",\n      \"pmids\": [\"33744762\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MTA3 is an integral, context-dependent subunit of the Mi-2/NuRD transcriptional corepressor complex that directly represses target gene promoters (including Snail, CGB5, CRIP2, TGFB1, and SOX2OT) and physically interacts with partners including BCL-6, GATA3, HDAC1, HDAC2, HDAC11, and SIX3/LSD1; in breast epithelial cells it is estrogen-dependent and suppresses EMT by repressing Snail/E-cadherin signaling, in germinal center B cells it mediates BCL-6-dependent repression of plasma cell fate in an acetylation-sensitive manner, in T follicular helper cells it is recruited by the BCL-6 middle domain to repress Blimp1, in granulosa cells it interacts with cohesin (RAD21) to regulate G2/M progression, and in Leydig cells its expression is driven by NR4A1 and supports steroidogenesis; genetic studies confirm synthetic lethality between Mta3 and Mta1 null alleles in mice, establishing partial functional redundancy within the NuRD complex.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MTA3 is a context-dependent subunit of the Mi-2/NuRD transcriptional corepressor complex that confers cell-type-specific gene repression across epithelial, immune, germ, and developmental programs [#0, #1]. In breast epithelial cells MTA3 acts downstream of estrogen receptor to repress the transcriptional repressor Snail, sustaining E-cadherin expression and restraining invasive growth [#0]; this same MTA3–Snail axis is recapitulated in trophoblast cells, where MTA3 directly occupies and represses the Snail and CGB5 promoters [#5]. In germinal center B cells MTA3 is recruited by the transcription factor BCL-6 to repress plasma cell differentiation genes, an interaction sensitive to BCL-6 acetylation [#1], and in T follicular helper cells the BCL-6 middle domain recruits MTA3 to silence Prdm1/Blimp1, with acetylation-mimetic BCL-6 blocking recruitment and derepressing the target [#6]. MTA3 partners with NuRD subunits and chromatin regulators including CHD4, HDAC1, HDAC2, and HDAC11, the last binding MTA3 through its N-terminal region to form a NuRD(MTA3) complex that represses TGFB1 [#4, #8, #14, #19], and it assembles with sequence-specific factors such as GATA3 and a SIX3/LSD1 module to repress targets including SOX2OT and EMT-associated genes [#9, #11]. Beyond transcriptional repression, MTA3 interacts with the cohesin subunit RAD21 and supports G2/M progression in granulosa cells [#4], drives steroidogenesis in Leydig cells under transcriptional control by NR4A1 [#7, #15], and is required for primitive hematopoiesis upstream of scl/lmo2 in zebrafish [#3]. MTA3 and its paralog MTA1 mutually repress one another's transcription and are genetically redundant, as compound Mta3-BAH-deletion/Mta1-null mice are synthetically lethal [#16, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established MTA3 as a functional NuRD subunit linking estrogen signaling to epithelial integrity, answering whether MTA-family proteins have distinct, regulated roles in gene repression.\",\n      \"evidence\": \"Co-IP, RNAi, reporter assays and epistasis in breast epithelial cells\",\n      \"pmids\": [\"12705869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical mechanism of Snail promoter recruitment not resolved\", \"Did not address non-epithelial contexts\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed MTA3 is a cell-type-specific NuRD subunit recruited by a sequence-specific transcription factor (BCL-6), explaining how NuRD achieves lineage-restricted repression.\",\n      \"evidence\": \"Reciprocal Co-IP, RNAi, expression profiling in germinal center B cells\",\n      \"pmids\": [\"15454082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of acetylation-sensitive BCL-6/MTA3 interaction not defined\", \"In vivo requirement not tested at this stage\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed Mta3-NuRD in a developmental hierarchy, demonstrating it is required upstream of scl/lmo2 for primitive hematopoiesis.\",\n      \"evidence\": \"Morpholino knockdown with scl/lmo2 rescue and HDAC inhibitor phenocopy in zebrafish\",\n      \"pmids\": [\"19864643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes of Mta3 in hematopoietic precursors not identified\", \"Mammalian conservation of this hierarchy untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected MTA3 regulation to ERβ signaling and dietary phytoestrogens, extending estrogen control of the MTA3/Snail/E-cadherin axis to choriocarcinoma invasion.\",\n      \"evidence\": \"ERβ siRNA epistasis with invasion assays and molecular readouts in JAR cells\",\n      \"pmids\": [\"22866146\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ERβ regulates MTA3 directly or indirectly unresolved\", \"Single cell-line context\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the in vivo recruitment determinant, showing the BCL-6 middle domain recruits MTA3 to repress Blimp1 and that BCL-6 acetylation gates this in T follicular helper differentiation.\",\n      \"evidence\": \"BCL-6 K379Q knock-in, ChIP, Prdm1-ablation rescue in vivo\",\n      \"pmids\": [\"26460037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full target repertoire beyond Prdm1 not mapped\", \"Does not address other NuRD subunit contributions\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed a non-canonical role beyond transcriptional repression, linking MTA3 to cohesin and cell-cycle control.\",\n      \"evidence\": \"In vivo Co-IP with CHD4/HDAC1/RAD21 plus RNAi with rescue and cell-cycle analysis in granulosa cells\",\n      \"pmids\": [\"22075476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which MTA3 promotes G2/M progression unresolved\", \"Whether the RAD21 interaction is transcriptional or structural unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided direct evidence of promoter occupancy, demonstrating MTA3 binds and represses Snail and CGB5 promoters in trophoblasts.\",\n      \"evidence\": \"ChIP, siRNA, promoter-luciferase, qRT-PCR\",\n      \"pmids\": [\"23510993\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Recruiting transcription factor at these promoters not identified\", \"NuRD subunit composition at these loci not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established a tissue-specific role for MTA3 in testicular steroidogenesis distinct from its repressive functions.\",\n      \"evidence\": \"shRNA knockdown and overexpression rescue with hormone-stimulated progesterone assays in MA-10 Leydig cells\",\n      \"pmids\": [\"27673553\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcriptional targets driving steroidogenesis unknown\", \"Whether NuRD complex is involved here untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Expanded the MTA3 interactome and reinforced its EMT-suppressive role in trophoblast invasion, and identified a SIX3/LSD1 NuRD(MTA3) module suppressing breast cancer EMT.\",\n      \"evidence\": \"Co-IP/mass spectrometry (71 partners), invasion assays, and AP-MS with ChIP-on-chip\",\n      \"pmids\": [\"28959722\", \"29463994\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional contribution of most identified partners untested\", \"Direct vs indirect nature of many interactions unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified an upstream regulatory axis, showing miR-146a-5p represses MTA3 via its 3'UTR to impair steroidogenesis under BPA exposure.\",\n      \"evidence\": \"3'UTR luciferase reporter, miR overexpression, hMTA3 rescue in Leydig cells\",\n      \"pmids\": [\"29746863\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of miR-146a-5p targeting in vivo limited\", \"Downstream steroidogenic targets not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated MTA3 partners with GATA3 to repress an lncRNA (SOX2OT), linking MTA3 to control of cancer stemness via the SOX2OT/SOX2 axis.\",\n      \"evidence\": \"Co-IP, ChIP, overexpression/knockdown and in vivo tumor models in ESCC\",\n      \"pmids\": [\"31810000\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GATA3 directly recruits MTA3 to the SOX2OT locus structurally unresolved\", \"Single tumor type\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended MTA3 function to therapy resistance and immune evasion, showing it represses CRIP2 to activate NF-κB and gemcitabine resistance, and acts downstream of SPHK1 to regulate PD-L1.\",\n      \"evidence\": \"CRISPR activation screen, ChIP, PDX models, and immunocompetent tumor models with T-cell co-culture\",\n      \"pmids\": [\"35981571\", \"36050478\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanism of PD-L1 transcriptional regulation by MTA3 not detailed\", \"Context dependence of pro- vs anti-tumor MTA3 roles unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined NR4A1 as a transcriptional activator of MTA3 in Leydig cells, integrating MTA3 into oxidative-stress-sensitive steroidogenic control.\",\n      \"evidence\": \"NR4A1 transactivation assays, overexpression rescue, in vivo lentiviral replenishment in diabetic mice\",\n      \"pmids\": [\"35239504\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct NR4A1 binding site on MTA3 promoter not mapped\", \"Mechanistic link between MTA3 and steroidogenic enzymes unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed MTA3 physically interacts with and downregulates HDAC2, suppressing NSCLC migration via reduced c-Myc and cyclin D1.\",\n      \"evidence\": \"Co-IP, CRISPR-edited cell lines, wound-healing/Transwell assays, qRT-PCR\",\n      \"pmids\": [\"37401867\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which MTA3 lowers HDAC2 levels unclear\", \"Reconciliation of HDAC2 partnership vs repression untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed a mutual transcriptional repression loop between MTA3 and MTA1 that estrogen disrupts, framing MTA3 as an antagonist of MTA1-driven breast cancer stemness/EMT.\",\n      \"evidence\": \"ChIP, luciferase reporter, ubiquitination assay, in vitro/in vivo functional assays\",\n      \"pmids\": [\"39154024\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative balance setpoint of the MTA1/MTA3 loop not defined\", \"Role of TRIM21-mediated MTA1 stability in the loop incompletely resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended MTA3 to fibroblast biology, placing it upstream of p38 MAPK/E2F1 in suppressing fibroblast-to-myofibroblast transition, and defined an HDAC11-MTA3 complex repressing TGFB1.\",\n      \"evidence\": \"Overexpression, E2F1 RNAi, SB203580 inhibition and MI model; GST pull-down/Co-IP with transcriptomics in HCC\",\n      \"pmids\": [\"40615041\", \"41547814\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional targets bridging MTA3 to p38/E2F1 not identified\", \"Whether HDAC11-MTA3 acts at the TGFB1 promoter directly via ChIP not shown in narrative\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided in vivo genetic proof of functional redundancy within NuRD, showing Mta3 BAH-domain loss is tolerated alone but synthetically lethal with Mta1 null.\",\n      \"evidence\": \"CRISPR deletion, synthetic lethality crosses, conditional B-cell deletion in mice\",\n      \"pmids\": [\"40758820\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular function of the MTA3 BAH domain not defined\", \"Shared vs distinct target genes underlying redundancy not mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MTA3 selects between repressive (Snail, Blimp1, CRIP2, TGFB1) and context-specific activating/structural roles (steroidogenesis, cohesin/cell cycle, PD-L1) within a single NuRD framework remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying biochemical model distinguishing MTA3 target selection across tissues\", \"Structural determinants of partner-specific recruitment undefined\", \"Genome-wide direct target maps across cell types incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 5, 6, 11, 12, 16, 19]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 6, 11, 12, 16]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 6, 9, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 1, 4, 19]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 5, 6, 11, 12, 16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 6, 7]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 6, 13, 18]}\n    ],\n    \"complexes\": [\n      \"Mi-2/NuRD complex\"\n    ],\n    \"partners\": [\n      \"BCL6\",\n      \"GATA3\",\n      \"HDAC1\",\n      \"HDAC2\",\n      \"HDAC11\",\n      \"CHD4\",\n      \"RAD21\",\n      \"MTA1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}